Home/Pipeline/MTR® for Traumatic Brain Injury

MTR® for Traumatic Brain Injury

Traumatic Brain Injury (TBI)

Phase 1Active

Key Facts

Indication

Traumatic Brain Injury (TBI)

Phase

Phase 1

Status

Active

Company

Renovo Concepts

About Renovo Concepts

Renovo Concepts is pioneering a new therapeutic approach for traumatic injuries with its Mechanical Tissue Resuscitation (MTR®) platform. Founded by the inventors of the widely adopted V.A.C. negative pressure wound therapy, the company is initially targeting traumatic brain injury (TBI), a condition with significant unmet need and little innovation in over a century. The company is currently conducting first-in-human clinical trials, positioning its lead program at an early clinical stage with potential applications in other organ systems like the heart and spinal cord.

View full company profile

Therapeutic Areas

Traumatic Brain Injury Spinal Cord Injury Cardiology

Other Traumatic Brain Injury (TBI) Drugs

Drug	Company	Phase	Status
Electroceutical® Therapy	Endonovo Therapeutics	Research	Active
IQool™ System	BrainCool	Clinical Evaluation	Investigational
Unnamed programs	Astrocyte Pharmaceuticals	Preclinical	Research stage
MAP4343	Mapreg	Preclinical	Active
LG3	Stream Biomedical	Pre-clinical	Active
NeuroSTAT® (OWL-1410)	Owl Therapeutics	Pre-clinical	Active
Autologous Wnt-activated ADSC Therapy	Regeneration Biomedical	Pre-clinical	Active
IRRAflow System	IRRAS	Clinical Evaluation	Active